Literature DB >> 32190324

Evaluation of risk factors for lymph node metastasis in T2 lower rectal cancer to perform chemoradiotherapy after local resection.

Hajime Ushigome1, Masayuki Ohue1, Masaki Kitamura2, Shinichi Nakatsuka2, Naoaki Haraguchi1, Junichi Nishimura1, Masayoshi Yasui1, Hiroshi Wada1, Hidenori Takahashi1, Takeshi Omori1, Hiroshi Miyata1, Masahiko Yano1, Shuji Takiguchi3.   

Abstract

The oncological outcome of chemoradiotherapy (CRT) after local excision (LE) for T2 lower rectal cancer has demonstrated a high local recurrence (LR) rate. The aim of the present study was to determine the risk factors for lymph node metastasis (LNM) in order to reduce LR in T2 lower rectal cancer after LE and CRT. Specimens were collected from 95 consecutive patients with T2 lower rectal adenocarcinoma who underwent R0 resection by total mesenteric excision or tumor-specific mesenteric excision between January 2008 and December 2018 at Osaka International Cancer Institute. All specimens were checked and evaluated to determine the risk factors for LNM. LNM was observed in 26 patients (27%), including 2 patients (2%) with lateral pelvic lymph node metastasis. Univariate analysis indicated lymphovascular invasion (LVI; P=0.008), tumor budding (P=0.012) and histology other than well-differentiated adenocarcinoma (P=0.08) were associated with LNM; multivariate analysis revealed that LVI (P=0.03) was the only independent risk factor for LNM. LNM was confirmed in 0% (0/8) of patients without LVI, tumor budding and histological type. LVI, tumor budding and histological type can be risk factors for LNM in lower rectal cancer. The present study may be helpful to select patients for performing LE and CRT with good oncological outcome.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  chemoradiotherapy; lymph node metastasis; rectal cancer

Year:  2020        PMID: 32190324      PMCID: PMC7057958          DOI: 10.3892/mco.2020.1993

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  20 in total

1.  Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer.

Authors:  Pei-Rong Ding; Xin An; Yun Cao; Xiao-Jun Wu; Li-Ren Li; Gong Chen; Zhen-Hai Lu; Yu-Jing Fang; De-Sen Wan; Zhi-Zhong Pan
Journal:  J Gastrointest Surg       Date:  2010-10-05       Impact factor: 3.452

2.  Tumor budding and evidence-based treatment of T2 rectal carcinomas.

Authors:  Tadahiko Masaki; Hiroyoshi Matsuoka; Masanori Sugiyama; Nobutsugu Abe; Atsuhiko Sakamoto; Toshiaki Watanabe; Hirokazu Nagawa; Yutaka Atomi
Journal:  J Surg Oncol       Date:  2005-10-01       Impact factor: 3.454

3.  Serial evaluation of anorectal function following low anterior resection of the rectum.

Authors:  S J Lee; Y S Park
Journal:  Int J Colorectal Dis       Date:  1998       Impact factor: 2.571

Review 4.  Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.

Authors:  W A A Borstlap; T J Coeymans; P J Tanis; C A M Marijnen; C Cunningham; W A Bemelman; J B Tuynman
Journal:  Br J Surg       Date:  2016-06-15       Impact factor: 6.939

5.  Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review.

Authors:  Hao-Cheng Chang; Shih-Chiang Huang; Jinn-Shiun Chen; Reiping Tang; Chung Rong Changchien; Jy-Ming Chiang; Chien-Yuh Yeh; Pao-Shiu Hsieh; Wen-Sy Tsai; Hsin-Yuan Hung; Jeng-Fu You
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

6.  Local excision of rectal cancer without adjuvant therapy: a word of caution.

Authors:  J Garcia-Aguilar; A Mellgren; P Sirivongs; D Buie; R D Madoff; D A Rothenberger
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

7.  Is pT2 subclassification feasible to predict patient outcome in colorectal cancer?

Authors:  Lin-lin Tong; Peng Gao; Zhen-ning Wang; Zhen-yu Yue; Yong-xi Song; Zhe Sun; Yi Lu; Cheng-zhong Xing; Hui-mian Xu
Journal:  Ann Surg Oncol       Date:  2010-11-24       Impact factor: 5.344

8.  Histological categorisation of fibrotic cancer stroma in advanced rectal cancer.

Authors:  H Ueno; A M Jones; K H Wilkinson; J R Jass; I C Talbot
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

9.  [Analysis of risk factors associate with lymph node metastasis of T1 and T2 rectal cancer].

Authors:  Jian He; Zheng Lou; Wei Zhang; Ronggui Meng; Chuangang Fu; Enda Yu; Hao Wang; Liqiang Hao; Hantao Wang
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2015-10

10.  Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.

Authors:  Takeshi Sasaki; Yoshinori Ito; Masayuki Ohue; Yukihide Kanemitsu; Takaya Kobatake; Masaaki Ito; Yoshihiro Moriya; Norio Saito
Journal:  Dis Colon Rectum       Date:  2017-09       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.